Monitoring of molecular responses to tirabrutinib in a cohort of exceptional responders with relapsed/refractory mantle cell lymphoma
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Description
Publication status: Published
Funder: King Faisal Medical City for Southern Regions
Funder: The Scott‐Waudby Trust
Funder: Hope Against Cancer charity
Keywords
Is Part Of
Publisher
Publisher DOI
Rights and licensing
Except where otherwised noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/
Sponsorship
CRUK‐NIHR Leicester Experimental Cancer Medicine Centre (C10604/A25151)
MRC—Impact Acceleration Accounts (MR/X502777/1)
MRC—Impact Acceleration Accounts (MR/X502777/1)